20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9723 | GluR6 antagonist-1 | Src | |
GluR6 antagonist-1 inhibits the pY binding site of tyrosine kinase p56lck SH2 domain. | |||
TQ0046 | Bavisant | JNJ-31001074 | Histamine Receptor |
Bavisant (JNJ-31001074) is a selective and orally active Human H3 receptor antagonist. Bavisant can be used in research on mechanisms of action, involving wakefulness and cognition and the treatment for ADHD. | |||
T8944 | TTA-A2 | Calcium Channel | |
TTA-A2 is a selective T-type calcium channel antagonist as a potent anticonvulsant that the Cav3.1 isoform plays a prominent role in mediating. TTA-A2 is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels ... | |||
T8930 | CID44216842 | KUC103479N-02 | CDK , Ras |
CID44216842 (KUC103479N-02) is a potent Cdc42-selective guanine nucleotide binding lead inhibitor. The EC50s for Cdc42 WT and Cdc42Q61L mutant are 1.0 and 1.2 μM in GTP binding assay, respectively. The EC50s for Cdc42 WT... | |||
T6950 | PNU-120596 | NSC 216666 | AChR |
PNU-120596 (NSC-216666) is a positive allosteric modulator of α7 nAChR with EC50 of 216 nM. | |||
T15247 | ESI-05 | NSC 116966 | cAMP |
ESI-05 (NSC-116966) is a specific EPAC2 (exchange protein directly activated by cAMP 2) antagonist (IC50: 0.4 μM). ESI-05 inhibits cAMP-mediated activation of EPAC2, as well as EAPC2, mediated Rap1 activation. | |||
T27838 | Lirequinil | RO413696,RO-413696,RO41-3696,RO 413696,Ro 41-3696,Ro-41-3696 | GABA Receptor |
Lirequinil (Ro 41-3696) is a small molecule GABAA receptor agonist used to study neurological disorders. | |||
T68063 | Elopiprazole | DU 29840 | Others |
Elopiprazole(DU 29840) is an anti-neurological compound that can be used to study neurological disorders. | |||
T10056 | Neurokinin antagonist 1 | Neuropeptide Y Receptor | |
Neurokinin antagonist 1 is a potent is a neuropeptide antagonist that can be used to study neurological disorders. | |||
T28258 | Org-13011 fumarate | Org13011,Org 13011 | 5-HT Receptor |
Org-13011 fumarate1 is an agonist of the 5-HT1A receptor and can be used to study neurological disorders. | |||
T22736 | DMeOB | 3,3'-Dimethoxybenzaldazine | GluR |
DMeOB (3,3'-Dimethoxybenzaldazine) is a negative regulator with mGluR5 agonist activity and is used in the study of neurological disorders. | |||
T11424 | Glutaminyl Cyclase Inhibitor 1 | Guanylate cyclase | |
Glutaminyl Cyclase Inhibitor 1 is a glutaminyl cyclase inhibitor (IC50: 0.5 μM) that can be used to study neurological disorders. | |||
T11278 | FG8119 | NNC13-8119 | Others |
FG8119 is a novel benzodiazepine agonist with potential anticonvulsant and antiepileptic activity for the study of neurological disorders. | |||
T15655 | KFM19 | Adenosine Receptor | |
KFM19 is a potent and selective adenosine receptor (A1-receptor) antagonist (IC50 : 50 nM) for the study of neurological disorders. | |||
T27143 | Delucemine Hydrochloride | NPS 1506,Delucemine,Delucemine HCl,NPS1506,NPS-1506 | NMDAR |
Delucemine Hydrochloride (Delucemine) is a polyamine NMDA receptor antagonist used in the study of neurological disorders such as depression and Alzheimer's disease. | |||
T28441 | PPI-1019 | PPI1019,Apan | Beta Amyloid |
PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD). | |||
T22638 | CBiPES hydrochloride | CBiPES HCl | GluR |
CBiPES hydrochloride (CBiPES HCl) is a potent orthosteric modulator of the mGlu2 receptor with an EC50 value of 92.8 nM.CBiPES hydrochloride blocks the action of WT and mGlu(3) receptors.CBiPES hydrochloride can be used ... | |||
T68035 | Capeserod | SL-650155,SL-65.0155 | 5-HT Receptor |
Capeserod is a potential 5-HT4 receptor (5-hydroxytryptamine receptor 4) agonist for the study of digestive disorders and neurological disorders. | |||
T67954 | Endixaprine | SR 41378 | |
Endixaprine (SR 41378) is a small molecule compound used to treat neurological disorders and may be used to study anxiety disorders and epilepsy. | |||
T31354 | Decimemide | V 285,V-285,V285 | Others |
Decimemide (V-285) is an alkoxybenzoic acid derivative with antiepileptic activity and potential anticonvulsant activity that can be used to study neurological disorders. |